Related Experiment Video
Updated: Aug 29, 2026

09:02
Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
[Palliative combined chemotherapy in patients with inoperable primary liver cancer]
Likars'Ka Sprava
|January 16, 2004
Abstract:
The subjective, objective evidences of status of 61 patients with primary liver cancer were studied. The patients were divided into two groups. The first group underwent a course of chemotherapy, the second group--combined chemotherapy with ericsin as an immunomodulator. Decrease of pain sensation, less side effects of treatment, improvement of general state and life style of the patients were observed in the second group thus giving us an opportunity to run refresher courses of treatment.

